A target trial emulation of adults with diabetes found that GLP-1 drugs were linked to a higher risk of hair loss compared ...

Health news and commentary gathered by MedPage Today staff ...

An FDA advisory committee voted Thursday to remove compounding restrictions on two peptides -- BPC-157 and KPV -- despite little evidence the products are safe or effective for medical use. BPC-157, ...

A glucagon and GLP-1 receptor dual agonist showed promise for reducing liver fat in a phase II study of patients with metabolic dysfunction-associated steatotic liver disease and steatohepatitis. ( ...

The following contains links to social media websites including Bluesky, X, TikTok, Instagram, Facebook, and LinkedIn. Public health professional Alex Sundermann, DrPH, explained that determining ...

Exceptional memory at age 80 and beyond was not due simply to good genes, an analysis of prospective data suggested. The study assessed outcomes for superagers -- people 80 or old ...

The Senate health committee delayed a planned vote Thursday on whether to advance the nomination of Erica Schwartz, MD, MPH, to lead the CDC. The committee plans to vote next week on whether to ...

Classic dermatomyositis (DM) had a significant association with postural orthostatic tachycardia syndrome (POTS), a retrospective study found. Patients with DM and concurrent POTS were all women and ...

Defense Secretary Pete Hegseth's new initiative to test and treat troops for low testosterone has prompted a federal judge to question the differences between that kind of testosterone replacement ...

The FDA approved zidesamtinib (Jideytro) for previously treated adults with locally advanced or metastatic ROS1-positive ...

President Donald Trump said that generic drugs imported into the U.S. will face a 100% levy starting in August 2028, which ...

The trial of Lindsay Clancy, a former labor and delivery nurse at Massachusetts General Hospital, could take several weeks ...